ISRCTN93864182
Completed
Phase 2
Phase II/III study to investigate the efficacy of 5-aminolaevulinic acid (ALA)-based photodynamic therapy in the treatment of Bowen's disease, actinic keratoses and study the effect of dose fractionation for superficial basal cell carcinomas
Department of Health (UK)0 sites0 target enrollmentSeptember 12, 2003
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Bowen's disease
- Sponsor
- Department of Health (UK)
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Recruited from clinical oncology consultants to whom patients are referred at a district general hospital. Also direct from consultant dermatologists/plastic surgeons in Leeds and Airedale.
Exclusion Criteria
- •Does not match inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
MK-5172 + MK-8742 in HCV-infected subjects with hepatic insufficiency (CP-B)Hepatitis CMedDRA version: 18.0Level: LLTClassification code 10019751Term: Hepatitis C virusSystem Organ Class: 100000004848Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2014-000672-25-ITMERCK SHARP & DOHME CORP. UNA SUSSIDIARIA DI MERCK & CO. INC.6
Active, not recruiting
Phase 1
Clinical trial to evaluate the efficacy and the safety of a combination of bendamustine-melphalan as preparative regimen to autologous transplantation of hematopoietic cells for multiple myeloma who did not responded after previous high-dose therapyMultiple myelomaTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2014-000130-37-ITFONDAZIONE NEOPLASIE SANGUE ONLUS (FO.NE.SA. Onlus)73
Active, not recruiting
Not Applicable
Prospective phase II trial evaluating efficacy of Trastuzumab therapy in HER2 FISH positive and/or HER2 mutation positive, pretreated, Non-Small Cell Lung Cancer patients (MO20509) - NDEUCTR2007-003709-29-ITISTITUTO CLINICO HUMANITAS
Recruiting
Phase 2
A phase II study to evaluate the effectiveness of S-1 + Cetuximab for patients with advanced/recurrent colon cancer who cannot undergo intensive therapyadvanced/recurrent colon cancer patients with RAS wild-type tumors who cannot undergo intensive therapyJPRN-UMIN000018484HO HOKKAIDO CANCER CENTER Division of Gastroenterology57
Active, not recruiting
Phase 1
Clinical trial to evaluate the effect of vitamin D on renal progression in patients with Chronic Kidney Disease and vitamin D deficiencyEUCTR2016-002913-23-ESFundación Hospital Alcorcón170